Argitalpenak (9) Javier Botet Rodríguez argitalpenak

2020

  1. Further delineation of neuropsychiatric findings in Tatton-Brown-Rahman syndrome due to disease-causing variants in DNMT3A: seven new patients

    European Journal of Human Genetics, Vol. 28, Núm. 4, pp. 469-479

2017

  1. Mitochondria and lipid raft-located FOF1-ATP synthase as major therapeutic targets in the antileishmanial and anticancer activities of ether lipid edelfosine

    PLoS Neglected Tropical Diseases, Vol. 11, Núm. 8

2015

  1. Chromosome segregation and organization are targets of 5′-Fluorouracil in eukaryotic cells

    Cell Cycle, Vol. 14, Núm. 2, pp. 206-218

  2. Genomic profiling of fungal cell wall-interfering compounds: Identification of a common gene signature

    BMC Genomics, Vol. 16, Núm. 1

2013

  1. Drug uptake, lipid rafts, and vesicle trafficking modulate resistance to an anticancer lysophosphatidylcholine analogue in yeast

    Journal of Biological Chemistry, Vol. 288, Núm. 12, pp. 8405-8418

  2. New insights into the RNA-based mechanism of action of the anticancer drug 5′-fluorouracil in eukaryotic cells

    PLoS ONE, Vol. 8, Núm. 11

2009

  1. Genome-wide analysis of factors affecting transcription elongation and DNA repair: A new role for PAF and Ccr4-not in transcription-coupled repair

    PLoS Genetics, Vol. 5, Núm. 2

2008

  1. A chemical genomic screen in Saccharomyces cerevisiae reveals a role for diphthamidation of translation elongation factor 2 in inhibition of protein synthesis by sordarin

    Antimicrobial Agents and Chemotherapy, Vol. 52, Núm. 5, pp. 1623-1629

2007

  1. A chemogenomic screening of sulfanilamide-hypersensitive Saccharomyces cerevisiae mutants uncovers ABZ2, the gene encoding a fungal aminodeoxychorismate lyase

    Eukaryotic Cell, Vol. 6, Núm. 11, pp. 2102-2111